ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2672

Ultrasonography in the Diagnosis of Giant Cell Arteritis

ROK JESE 1, Ziga Rotar 1, Matija Tomšič 2 and Alojzija Hocevar3, 1UMC LJUBLJANA, DPT. OF RHEUMATOLOGY, LJUBLJANA, Slovenia, 2Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia, LJUBLJANA, Slovenia, 3Department of Rheumatology, University Medical Center Ljubljana, Slovenia, LJUBLJANA, Slovenia

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: giant cell arteritis and Doppler ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 12, 2019

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III: Giant Cell Arteritis

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Imaging has been recently recognized as a tool equivalent to the temporal artery biopsy in diagnosing giant cell arteritis (GCA). Amongst a variety of imaging modalities, color Doppler Ultrasonography (CDS) is the most convenient. We aimed to evaluate the frequency of cranial- and aortic arch-artery involvement in GCA using CDS.

Methods: We performed CDS examination of cranial and aortic arch arteries in new, clinically diagnosed GCA patients between October 2013 and April 2019, using a Philips IU22 with 5–17.5 MHz linear probe or Philips Epiq 7 with 5–18.5 MHz linear probe. Temporal, facial, occipital, thyroid, carotid, vertebral, subclavian, and axillary arteries were examined bilaterally. A halo with positive compression sign was considered a positive finding. Additionally, the thickness of intima-media complex was measured. .

Results: During the 67-month period 212 newly diagnosed GCA patients (63.2% females, median (IQR) age 75.4 (67.2-80.8) years) underwent vascular CDS evaluation. CDS was performed prior to glucocorticoid initiation in 201 patients (94.8%), and delayed by a median (IQR) of 1 (1-3) days (range 1-6 days) for the rest.

The CDS was positive in 208 (98.1%) patients in at least one of the examined arteries. Temporal arteries, involved in 167 (78.8%) patients, were the most commonly affected vessels. Extracranial large vessel involvement (LVV) was found in 70 (33.0%) patients (30 patients had isolated LVV, and 40 concomitant temporal artery involvement). Among the 142 patients without LVV, 11(5.2% of the studied cohort) had involvement of cranial arteries other than temporal arteries (we found facial, occipital and thyroid artery involvement in 9, 3 and 2 patients, respectively). Table 1 shows the frequency of individual vessel involvement and the intima-media thickness of inflamed and non-inflamed arteries.

Conclusion: CDS of eight preselected cranial and aortic arch arteries provides a high diagnostic yield in GCA.

Table 1. Involvement of cranial and aortic arch arteries in GCA assessed by CDS


Disclosure: R. JESE, None; Z. Rotar, AbbVie, 9, Amgen, 5, 8, Eli-Lilly, 9, MSD, 5, Novartis, 9, Pfizer, 9, Sanofi, 5; M. Tomšič, None; A. Hocevar, None.

To cite this abstract in AMA style:

JESE R, Rotar Z, Tomšič M, Hocevar A. Ultrasonography in the Diagnosis of Giant Cell Arteritis [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/ultrasonography-in-the-diagnosis-of-giant-cell-arteritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasonography-in-the-diagnosis-of-giant-cell-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology